Monday, November 22, 2021

Pharma Reviews: Boehringer Ingelheim gets DCGI approval to market Jardiance in India with additional heart ...

Jardiance received approval from the US Food and Drug Administration (USFDA), earlier this year in August, for the heart failure indication.
Read more: Boehringer Ingelheim gets DCGI approval to market Jardiance in India with additional heart ...